Novel Agent Granted Orphan Drug Designation for T-Cell Prolymphocytic Leukemia - Targeted Oncology https://t.co/FHsdu5bPLQ
— IDRO (@IDROOhio) March 30, 2019
from Twitter https://twitter.com/IDROOhio
March 29, 2019 at 10:02PM
Saturday, March 30, 2019
Novel Agent Granted Orphan Drug Designation for T-Cell Prolymphocytic Leukemia - Targeted Oncology https://t.co/FHsdu5bPLQ
from Twitter https://twitter.com/IDROOhio
March 29, 2019 at 10:02PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment